Cargando…
Long-acting injectable antiretrovirals for HIV treatment and prevention
PURPOSE OF REVIEW: Long-acting antiretroviral (ARV) drugs may improve adherence to therapy and extend opportunities for therapeutic or prophylactic intervention to underserved patient populations. This review focuses on recent advances in the development of small molecule long-acting injectable ARV...
Autores principales: | Spreen, William R., Margolis, David A., Pottage, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815009/ https://www.ncbi.nlm.nih.gov/pubmed/24100877 http://dx.doi.org/10.1097/COH.0000000000000002 |
Ejemplares similares
-
A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV
por: Bares, Sara H., et al.
Publicado: (2022) -
Ben Gurion, State-builder : principles and pragmatism, 1948-1963
por: Avi-Hai, Avraham, 1931-
Publicado: (1974) -
The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen
por: Venter, Willem D.F., et al.
Publicado: (2017) -
When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank
por: Vitoria, Marco, et al.
Publicado: (2017) -
The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment
por: Castor, Delivette, et al.
Publicado: (2020)